Kyle Rose
Stock Analyst at Canaccord Genuity
(2.60)
# 2,126
Out of 5,120 analysts
115
Total ratings
51.61%
Success rate
13.24%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $256.62 | +75.36% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $34.26 | -21.19% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $368.14 | +18.16% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $89.70 | -20.85% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $22.17 | +220.25% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $16.62 | +32.37% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.50 | +566.67% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $14.49 | +51.83% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $72.53 | +106.81% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $2.09 | +12,818.66% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $16.37 | +64.94% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.95 | +1,487.30% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $35.02 | -57.17% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $173.18 | -29.55% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $5.69 | -29.70% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.21 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $86.22 | +44.98% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $256.62
Upside: +75.36%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $34.26
Upside: -21.19%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $368.14
Upside: +18.16%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $89.70
Upside: -20.85%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $22.17
Upside: +220.25%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $16.62
Upside: +32.37%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.50
Upside: +566.67%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $14.49
Upside: +51.83%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $72.53
Upside: +106.81%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $2.09
Upside: +12,818.66%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $16.37
Upside: +64.94%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.95
Upside: +1,487.30%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $35.02
Upside: -57.17%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $173.18
Upside: -29.55%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $5.69
Upside: -29.70%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $8.21
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $86.22
Upside: +44.98%